Posts with tag: solo travel
Super Micro (SMCI) stock soars premarket after earnings update, Nasdaq delisting deadline extension
Published on: February 12, 2025, 01:02 PM UTC
Mercury General Corporation (MCY) reported fourth-quarter profit of $101.1 million, or $1.82 per share, and full-year profit of $468 million, or $8.45 per share. The auto insurance company posted revenue of $1.37 billion in the quarter and $5.39 billion for the year.
Published on: February 11, 2025, 10:07 PM UTC
Commonwealth Bank of Australia reports better-than-expected first-half cash earnings, driven by volume growth in home lending and deposits, and a lower loan impairment expense.
Published on: February 11, 2025, 09:00 PM UTC
Elon Musk, who plans to turn his company X into a digital payments platform, appears to be dismantling the agency overseeing that sector. The Trump administration has ordered a halt to work at the CFPB, which regulates large banks, mortgage lenders, student loan servicers, and online payment apps. Musk has supported this move, tweeting "CFPB RIP" and calling for its closure. The agency has also clashed with Silicon Valley, leading to calls for its dismantling. Critics worry that this move will benefit Musk by freeing his company X from government scrutiny.
Published on: February 11, 2025, 08:01 AM UTC
The first central bank interest rate moves of 2019 suggest it will be a year of contrasting fortunes, with some major economies heading in different directions.
Published on: February 07, 2025, 07:00 PM UTC
Google is reversing its diversity hiring targets, following scrutiny from Washington. Meanwhile, other tech giants like Apple and Microsoft maintain their DEI initiatives.
Published on: February 07, 2025, 02:03 PM UTC
Investors are bracing for a weaker pound as the Bank of England's policy decision highlights concerns about UK economic growth. Despite a slight recovery, sterling remains the weakest among G-10 currencies, with experts predicting further interest rate cuts and a potential drop to $1.19.
Published on: February 07, 2025, 01:04 PM UTC
Eli Lilly Q4 2024 earnings beat estimates, driven by strong GLP-1 drug sales, despite missing on expectations. Revenue increased 45% to $13.5 billion, and the company raised its 2025 guidance. Investors will focus on management's commentary on prescription volume and coverage dynamics for Mounjaro and Zepbound, as well as updates on orforglipron, a potential pill option for GLP-1 therapy.
Published on: February 06, 2025, 03:02 PM UTC
Apple stock dropped premarket after a Bloomberg report that China is weighing an antitrust probe into its app store policies following a similar move by regulators in the US.
Published on: February 05, 2025, 03:02 PM UTC
US stock futures fall as trade war escalates; Alphabet, AMD earnings disappoint; Disney earnings eyed
Published on: February 05, 2025, 09:01 AM UTC